Skip to main content
. 2017 Feb 18;17:155. doi: 10.1186/s12879-017-2248-5

Table 2.

Primary analysis

Screened for Chlamydia No screening
8% Prevalence
 Cost§ 256,305,162 131,664,935
 Treated Chlamydia 496,241 167,562
 PID 6393 23,658
 SAB 3 10
 Vertical Transmission 8211 37,050
 Neonatal conjunctivitis 6806 29,755
 Pneumonia 3093 13,585
 Premature 3 6
 Infertility 786 2910
 WTP: 19.34 ---
6.7% Prevalence
 Cost 249,087,114 106,421,100
 Treated Chlamydia 204,632 66,819
 PID 2673 9852
 SAB 3 9
 Vertical Transmission 4999 15,427
 Neonatal conjunctivitis 4101 12,386
 Pneumonia 1863 5659
 Premature 2 1
 Infertility 329 1222
 WTP: 22.14 ---
Threshhold-.169 prevalence
 Cost§ 279,158,019 279,151,574
 Treated Chlamydia 1,044,039 348,013
 PID 6528 49,985
 SAB 6 21
 Vertical transmission 9757 78,264
 Neonatal conjunctivitis 8301 62,855
 Pneumonia 3738 28,718
 Premature 5 19
 Infertility 810 6198
 WTP: 0 ---

PID pelvic inflammatory disease, SAB spontaneous abortion, WTP willingness to pay

§2015 USD